| Improving CNS delivery to brain metastases by blood–tumor barrier disruption SA Sprowls, TA Arsiwala, JR Bumgarner, N Shah, SS Lateef, ... Trends in cancer 5 (8), 495-505, 2019 | 85 | 2019 |
| Ultrasound Blood–Brain Barrier Opening and Aducanumab in Alzheimer’s Disease AR Rezai, PF D’Haese, V Finomore, J Carpenter, M Ranjan, ... New England Journal of Medicine 390 (1), 55-62, 2024 | 33 | 2024 |
| Ultrasound-mediated disruption of the blood tumor barrier for improved therapeutic delivery T.A.Arsiwala, S.A.Sprowls, K.E.Blethen, C.E.Adkins, P.A.Saralkar, R.A ... Neoplasia 23 (7), 676, 2021 | 31 | 2021 |
| Nanoparticle formulation and in vitro efficacy testing of the mitoNEET ligand NL-1 for drug delivery in a brain endothelial model of ischemic reperfusion-injury P Saralkar, T Arsiwala, WJ Geldenhuys International journal of pharmaceutics 578, 119090, 2020 | 23 | 2020 |
| Hypomethylating agent azacitidine is effective in treating brain metastasis triple-negative breast cancer through regulation of DNA methylation of keratin 18 gene C Butler, S Sprowls, G Szalai, T Arsiwala, P Saralkar, B Straight, ... Translational Oncology 13 (6), 100775, 2020 | 20 | 2020 |
| Modulation of the blood-tumor barrier to enhance drug delivery and efficacy for brain metastases KE Blethen, TA Arsiwala, RA Fladeland, SA Sprowls, DM Panchal, ... Neuro-Oncology Advances 3 (Supplement_5), v133-v143, 2021 | 15 | 2021 |
| The mitochondrial mitoNEET ligand NL-1 is protective in a murine model of transient cerebral ischemic stroke P Saralkar, A Mdzinarishvili, TA Arsiwala, YK Lee, PG Sullivan, MV Pinti, ... Pharmaceutical research 38 (5), 803-817, 2021 | 11 | 2021 |
| Effects of whole-brain radiation therapy on the blood-brain barrier in immunocompetent and immunocompromised mouse models KE Blethen, SA Sprowls, TA Arsiwala, CP Wolford, DM Panchal, ... Rad Oncology 19, 2023 | 9 | 2023 |
| Characterization of passive permeability after low intensity focused ultrasound mediated blood–brain barrier disruption in a preclinical model TA Arsiwala, SA Sprowls, KE Blethen, RA Fladeland, CP Wolford, ... Fluids and Barriers of the CNS 19 (1), 72, 2022 | 8 | 2022 |
| Overcoming the acquired resistance to gefitinib in lung cancer brain metastasis in vitro and in vivo Z Liu, N Shah, KL Marshall, SA Sprowls, P Saralkar, A Mohammad, ... Archives of toxicology 95 (11), 3575-3587, 2021 | 7 | 2021 |
| Blood-tumor barrier opening by MRI-guided transcranial focused ultrasound in a preclinical breast cancer brain metastasis model improves efficacy of combinatorial chemotherapy TA Arsiwala, KE Blethen, CP Wolford, DM Panchal, SA Sprowls, ... Frontiers in Oncology 13, 1104594, 2023 | 5 | 2023 |
| A Review of Mathematics Determining Solute Uptake at the Blood–Brain Barrier in Normal and Pathological Conditions SA Sprowls, P Saralkar, T Arsiwala, CE Adkins, KE Blethen, VJ Pizzuti, ... Pharmaceutics 13 (5), 756, 2021 | 2 | 2021 |
| BSBM-11 COMBINING IMMUNOTHERAPY AND WHOLE-BRAIN RADIATION THERAPY IN A NOVEL SYNGENEIC LUNG CANCER BRAIN METASTASIS PRECLINICAL MODEL: DOES TIMING OF ADMINISTRATION MATTER? K Blethen, S Sprowls, T Arsiwala, C Wolford, D Panchal, R Fladeland, ... Neuro-Oncology Advances 5 (Suppl 3), iii2, 2023 | 1 | 2023 |
| Radiation increases BTB permeability in a preclinical model of breast cancer brain metastasis. SA Sprowls, TA Arsiwala, BN Kielkowski, V Pizzuti, RAC Siochi, ... | 1 | 2020 |
| Coordination of anti-CTLA-4 with whole-brain radiation therapy decreases tumor burden during treatment in a novel syngeneic model of lung cancer brain metastasis KE Blethen, CP Wolford, GL Pecar, TA Arsiwala, E Adjeroh, LP Dykstra, ... Cancer Immunology, Immunotherapy 73 (1), 1-10, 2024 | | 2024 |
| BSBM-10 CHARACTERIZATION OF A RADIATION-RESISTANT MODEL OF LUNG CANCER BRAIN METASTASIS C Wolford, K Blethen, T Arsiwala, G Pecar, R Fladeland, D Panchal, ... Neuro-Oncology Advances 5 (Suppl 3), iii2, 2023 | | 2023 |
| Abstract P2-21-05: Vascular effects of Platelet-derived growth factor-B (PDGFB) in breast cancer metastasis to the brain S Shah, R Packard, S Steck, A Mossing, Y Ramamoorthy, K Thies, ... Cancer Research 83 (5_Supplement), P2-21-05-P2-21-05, 2023 | | 2023 |
| Focused ultrasound induced blood-tumor barrier permeability of combinatorial chemotherapy TA Arsiwala, KE Blethen, SA Sprowls, RA Fladeland, B Keilkowski, ... Cancer Research 82 (12_Supplement), 3461-3461, 2022 | | 2022 |
| Assessing DCE for optimizing FUS energy dose to open BBB of rabbit model of AD B Hou, J Carpenter, T Arsiwala, P Wang, D Wang, B Schreurs, P Lockman JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 42 (1_ SUPPL), 145-147, 2022 | | 2022 |
| Single exposure to low-intensity focused ultrasound causes biphasic opening of the blood-brain barrier on the sonicated and contralateral treated regions. TA Arsiwala, KE Blethen, CP Wolford, DM Panchal, BN Kielkowski, ... Exploiting modulation of the Blood-Brain and Blood-Tumor Barrier …, 2022 | | 2022 |
Pushkar SaralkarWest Virginia University, Pfizer在 mix.wvu.edu 的电子邮件经过验证
Pushkar SaralkarWest Virginia University, Pfizer在 mix.wvu.edu 的电子邮件经过验证
Werner GeldenhuysWest Virginia University在 hsc.wvu.edu 的电子邮件经过验证